WORLDWIDE IN THE NEWS

July 17, 2017

GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreement with Worldwide Clinical Trials, Inc.

LAS VEGAS, July 17, 2017 - GB Sciences, Inc. (OTCQB: GBLX) has signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. to evaluate the company’s intellectual property portfolio and to assist with p...

July 12, 2017

Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe

Medidata’s end-to-end Payments Cloud to help Worldwide change the CRO experience – accelerating accurate, timely payments NEW YORK – July 12, 2017 – Medidata (NASDAQ:...

July 3, 2017

BrainStorm Selects Worldwide Clinical Trials as its CRO for Phase 3 Trial in Amyotrophic Lateral Sclerosis (ALS)

HACKENSACK, N.J. and PETACH TIKVAH, Israel, July 3, 2017 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it ha...

June 21, 2017

Worldwide Clinical Trials Receives 2017 CRO Leadership Awards for Outstanding Capabilities, Compatibility, Expertise, Quality and Reliability

Worldwide Clinical Trials has been recognized for excellence in clinical research by Life Science Leader's 2017 CRO Leadership Awards. Worldwide came away a winner in 12 of the 15 potential categories in the annual award...

May 23, 2017

Worldwide Clinical Trials Appoints New Vice President of Clinical Operations, Site Management

MORRISVILLE, NC, MAY 23, 2017 – Worldwide Clinical Trials (www.worldwide.com) has announced the appointment of Karen Nowatkoski as Vice President of Clinical Operations, Site Man...

May 17, 2017

Worldwide Clinical Trials Founder Neal Cutler, M.D., Honored with 2017 European CEO Award

MORRISVILLE, NC, MAY 17, 2017 – Neal Cutler, M.D., Chief Executive Officer of Worldwide Clinical Trials (www.worldwide.com), has been named by the 2017 European CEO Awards as the...